Concept of emergence of a new coronavirus infection
https://doi.org/10.15690/pf.v17i6.2203
Abstract
This report presents a brief review of literature and the authors’ concept of the emergence of the novel coronavirus 19 infection. The purpose of the work is to show the significance of lysozyme deficiency in the pathogenesis of COVID-19 based on data from literature sources and the results of the authors’ past studies. The relevance of the study is due to the planetary scale of the spread of coronavirus infection, the appearance of SARS-CoV-2 with new aggressive signs, the difficulties of their treatment and prevention. Anatomo-functional connection of protective mechanisms of lysozyme, mucopolysaccharides of histohaematic barriers with preservation of immune, biochemical and tissue homeostasis is established. The loss of lysozyme, which has genetically determined enzymatic specificity, contributes to the development of damaging processes of immune, biochemical and tissue nature with manifestation in all organs and systems of the body. Inclusion of exogenous lysozyme in basic therapy and prophylaxis COVID-19 is proposed.
About the Authors
Valentina G. DorofeychouckRussian Federation
Moscow
Stella A. Sher
Russian Federation
Moscow
References
1. Baranov AA, Dorofeichuk VG. Lizotsim: teoriya i praktika. Moscow; Nizhnii Novgorod; 1999. 127 p. (In Russ).
2. Baranov AA, Dorofeichuk VG. Lechebnoe pitanie pri narusheniyakh zashchitnykh mekhanizmov pishchevaritel›nogo trakta u detei. Pediatriya. 1984;(6):73–75. (In Russ).
3. Borodulin VI. Pnevmokoniozy: spravochnik prakticheskogo vracha. Pod red. prof. A.I. Vorob’eva. Moscow: Meditsina; 1983. pp. 106–108. (In Russ).
4. Bukharin OV, Vasil›ev NV. Lizotsim i ego rol’ v biologii. Tomsk; 1974. 208 p. (In Russ).
5. Vasil›eva ZF, Shabalin VN. Immunologicheskie osnovy akusherskoi patologii. Moscow: Meditsina; 1984. 192 p. (In Russ).
6. Gistologiya. Gistogematicheskie bar’ery. (In Russ). Доступно по: https://www.referat911.ru/Medicina/gistologiya-gistogematicheskie-barery/308288-2680874-place1.html. Ссылка активна на 01.06.2020.
7. Dorofeichuk VG., Volkov AI., Karaseva GN, et al. Sposob polucheniya kislomolochnogo produkta. Avtorskoe svidetel’stvo № 1091380. 1984. (In Russ).
8. Dorofeichuk VG, Komarova LG. Sposob diagnostiki obostreniya bolezni zheludka i 12-perstnoi kishki. Avtorskoe svidetel’stvo № 1128909. 1984. (In Russ).
9. Dorofeichuk VG, Ershova AI, Medyanik NI. Sposob preduprezhdeniya nevynashivaniya beremennosti. Avtorskoe svidetel’stvo № 1297863. 1986. (In Russ).
10. Dorofeichuk VG, Salina EV, Mayanskaya IV et al. Sposob prognozirovaniya chastykh infektsionnykh zabolevanii u detei. Avtorskoe svidetel’stvo № 1332229. 1987. (In Russ).
11. Dorofeichuk VG. Mekhanizmy zashchitnoi funktsii lizotsima, fundamental›noe i prikladnoe znachenie. Nizhegorodskii meditsinskii zhurnal. 1996;(2):9– 13. (In Russ).
12. Dorofeichuk VG, Tolkacheva NI, Sher SA. Obshchebiologicheskaya funktsiya lizotsima pishchevaritel›nykh sekretov v obespechenii estestvennoi tolerantnosti organizma k geneticheski chuzherodnym agentam. Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii. Prilozhenie № 36. Materialy XVI Rossiiskoi gastroenterologicheskoi nedeli, 11–13 oktyabrya 2010 g. 2010;20(5):121. (In Russ).
13. Dorofeichuk VG, Tolkacheva NI, Shkeneva LN, et al. Lizotsim slyuny — indikator antigennoi nagruzki organizma. Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii. Prilozhenie № 38. Materialy XVII Rossiiskoi gastroenterologicheskoi nedeli. 2011;21(5): 179. (In Russ).
14. Dorofeichuk VG, Chuprov AD. Svoistvo endogennogo lizotsima neitralizovat’ vliyanie antigennykh faktorov na zhivoi organizm. Diplom na otkrytie № 435. 2012. (In Russ).
15. Lizotsim. (In Russ). Доступно по: https://www.xumuk.ru/encyklopedia/2319.html. Ссылка активна на 01.06.2020.
16. Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versiya 5. (08.04.2020). (In Russ). Доступно по: https://стопкоронавирус.рф/ai/doc/114/attach/vremennie_mr_COVID-19_versiya_5.pdf. Ссылка активна на 01.06.2020.
17. Ransberger K, Noi S. Enzimy i enzimoterapiya. Myunkhen: Meditsinskoe obshchestvo po izucheniyu enzimov; 1994. 243 p. (In Russ).
18. Corti G., Paradisi F. Pathogenic mechanisms responsible for producing a secondary immunodeficiency state. J Chemother. 1994;6 Suppl 3:6–10.
19. Dorofeychouk VG, Sher SA. Lysozyme theoretical and practical. In: The Second International Conference of Russian speaking Medical doctors, stomatologists and biologists. New York City, USA; 1998. p. 45.
20. Elsevier’s free health and medical research on the novel coronavirus (SARS-CoV-2) and COVID-19. // Available online: https://www.elsevier.com/connect/coronavirus-information-center. Accessed on June 2, 2020.
21. Jolles R., Berniod I. Lysozyme. In: Lysozyme Conference Arden House 1972. Osserman EF, Canfield RE, Beychok S, eds. New York: Academic Press; 1974. pp. 31–46.
22. Kivinen A, Tarpila S, Kiviluoto T, et al. Milk and egg phospholipids act as protective surfactants against luminal acid in Necturus gastric mucosa. Aliment Pharmacol Ther. 1995;9(6):685–691. doi: 10.1111/j.1365-2036.1995.tb00439.x
Review
For citations:
Dorofeychouck V.G., Sher S.A. Concept of emergence of a new coronavirus infection. Pediatric pharmacology. 2020;17(6):547-551. (In Russ.) https://doi.org/10.15690/pf.v17i6.2203